Forbion leads Promedior's $12 million series C round
16 March 2010
Sukaina Virji
Please Login to read the full article.
16 March 2010
Sukaina Virji
sukaina.virji@informa.com
Promedior has raised $12 million in a series C financing round. The clinical-stage US biotechnology company is developing therapies to treat inflammatory and fibrotic diseases.
Forbion Capital Partners, the only new investor, led the round with participation from existing investors Morgenthaler...
Please Login to read the full article.
RELATED CONTENT
FEATURES
- DKSH highlights one-stop benefits as it builds Asia market expansion services
- Merck BioVentures: where biosimilars make a difference
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
